MD Anderson and ARTIDIS Announce Strategic Alliance to Advance Nanomechanical Technology Platform for Optimizing Cancer Treatment
Similar Posts
NHS Opens Eight UK Clinical Trial Sites to Assess Cancer Patient Response to Immunotherapy in Collaboration with OncoHost
OncoHost’s AI-Based Proteomic Profiling Platform, PROphet, to Serve Key Role in Host Response Evaluation of Late-Stage Disease Patients OncoHost,…
Carequality Celebrates 10-Year Anniversary a Trusted Exchange Framework
Nearly 800 Million Documents Exchanged Monthly Carequality, the national-level, common interoperability trusted exchange framework to enable health information…
National Institutes of Health To Launch Million-Person All of Us Research Program
The National Institutes of Health is launching a historic research program to gather data from one million or more…
Thrive Global Acquires Boundless Mind, Neuroscience-based Artificial Intelligence Company to Power Health and Productivity Behavior Change
With acquisition of Boundless, the leader in behavior change AI, Thrive advances its core mission to help individuals and…
Veterans Health Administration, AdventHealth, OCHIN, & InterCommunity CCO Pioneer New eHealth Exchange Health Information Network Infrastructure
Network Participants Adopting Nationwide Gateway Service, Now Finalizing Carequality Implementation eHealth Exchange, the oldest and largest nationwide health information…
